-
Je něco špatně v tomto záznamu ?
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
K. Kotseva, G. De Backer, D. De Bacquer, L. Rydén, A. Hoes, D. Grobbee, A. Maggioni, P. Marques-Vidal, C. Jennings, A. Abreu, C. Aguiar, J. Badariene, J. Bruthans, A. Castro Conde, R. Cifkova, J. Crowley, K. Davletov, J. Deckers, D. De Smedt, J....
European journal of preventive cardiology.
2019 ;
26 (8) :
824-835.
[pub] 20190210
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
Perzistentní odkaz
https://www.medvik.cz/link/bmc20025871
PubMed
30739508
DOI
10.1177/2047487318825350
Knihovny.cz E-zdroje
- MeSH
- adherence pacienta MeSH
- chování snižující riziko * MeSH
- dieta škodlivé účinky MeSH
- hodnocení rizik MeSH
- kardiovaskulární látky terapeutické užití MeSH
- kardiovaskulární nemoci diagnóza epidemiologie patofyziologie prevence a kontrola MeSH
- kouření škodlivé účinky epidemiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- ochranné faktory MeSH
- průřezové studie MeSH
- průzkumy zdravotní péče MeSH
- registrace MeSH
- rizikové faktory MeSH
- sedavý životní styl MeSH
- sekundární prevence MeSH
- senioři MeSH
- statiny terapeutické užití MeSH
- výsledek terapie MeSH
- zdravotní stav MeSH
- zdravý životní styl * MeSH
- životní styl * MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
AIMS: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. DESIGN: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. METHODS: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. RESULTS: A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. CONCLUSION: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.
Assiut University Heart Hospital Cardiovascular Medicine Department Egypt
Cardiac Rehabilitation Unit Cardiology Department Hospital Universitario La Paz Madrid Spain
European Society of Cardiology Sophia Antipolis France 17 Erasmus MC Rotterdam The Netherlands
European Society of Cardiology Sophia Antipolis France 34 Varkaus Hospital Finland
European Society of Cardiology Sophia Antipolis France 7 ANMCO Research Centre Florence Italy
Hospital Santa Marta Centro Hospitalar de Lisboa Central Lisbon Portugal
National Heart Hospital Dept Cardiology Sofia Bulgaria
National Research Centre for Preventive Medicine Directorate Moscow Russia
Supyk National Medical Academy of Postgraduate Education Kiev Ukraine
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025871
- 003
- CZ-PrNML
- 005
- 20201222154129.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1177/2047487318825350 $2 doi
- 035 __
- $a (PubMed)30739508
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kotseva, Kornelia $u 1 European Society of Cardiology, Sophia Antipolis, France. 2 National Heart and Lung Institute, Imperial College London, UK.
- 245 10
- $a Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry / $c K. Kotseva, G. De Backer, D. De Bacquer, L. Rydén, A. Hoes, D. Grobbee, A. Maggioni, P. Marques-Vidal, C. Jennings, A. Abreu, C. Aguiar, J. Badariene, J. Bruthans, A. Castro Conde, R. Cifkova, J. Crowley, K. Davletov, J. Deckers, D. De Smedt, J. De Sutter, M. Dilic, M. Dolzhenko, V. Dzerve, A. Erglis, Z. Fras, D. Gaita, N. Gotcheva, P. Heuschmann, H. Hasan-Ali, P. Jankowski, N. Lalic, S. Lehto, D. Lovic, S. Mancas, L. Mellbin, D. Milicic, E. Mirrakhimov, R. Oganov, N. Pogosova, Z. Reiner, S. Stöerk, L. Tokgözoğlu, C. Tsioufis, D. Vulic, D. Wood, EUROASPIRE Investigators*,
- 520 9_
- $a AIMS: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. DESIGN: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. METHODS: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. RESULTS: A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. CONCLUSION: A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kardiovaskulární látky $x terapeutické užití $7 D002317
- 650 _2
- $a kardiovaskulární nemoci $x diagnóza $x epidemiologie $x patofyziologie $x prevence a kontrola $7 D002318
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a dieta $x škodlivé účinky $7 D004032
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a průzkumy zdravotní péče $7 D019538
- 650 _2
- $a zdravotní stav $7 D006304
- 650 12
- $a zdravý životní styl $7 D000070497
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a statiny $x terapeutické užití $7 D019161
- 650 12
- $a životní styl $7 D008019
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a adherence pacienta $7 D010349
- 650 _2
- $a ochranné faktory $7 D065840
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 12
- $a chování snižující riziko $7 D040242
- 650 _2
- $a sekundární prevence $7 D055502
- 650 _2
- $a sedavý životní styl $7 D057185
- 650 _2
- $a kouření $x škodlivé účinky $x epidemiologie $7 D012907
- 650 _2
- $a výsledek terapie $7 D016896
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a De Backer, Guy $u 1 European Society of Cardiology, Sophia Antipolis, France. 3 Department of Public Health and Primary Care, Ghent University, Belgium.
- 700 1_
- $a De Bacquer, Dirk $u 1 European Society of Cardiology, Sophia Antipolis, France. 3 Department of Public Health and Primary Care, Ghent University, Belgium.
- 700 1_
- $a Rydén, Lars $u 1 European Society of Cardiology, Sophia Antipolis, France. 4 Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Hoes, Arno $u 1 European Society of Cardiology, Sophia Antipolis, France. 5 Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands.
- 700 1_
- $a Grobbee, Diederick $u 1 European Society of Cardiology, Sophia Antipolis, France. 6 Julius Global Health, Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, The Netherlands.
- 700 1_
- $a Maggioni, Aldo $u 1 European Society of Cardiology, Sophia Antipolis, France. 7 ANMCO Research Centre, Florence, Italy.
- 700 1_
- $a Marques-Vidal, Pedro $u 1 European Society of Cardiology, Sophia Antipolis, France. 8 Department of Medicine, Internal Medicine, Lausanne University Hospital, Switzerland.
- 700 1_
- $a Jennings, Catriona $u 1 European Society of Cardiology, Sophia Antipolis, France. 2 National Heart and Lung Institute, Imperial College London, UK.
- 700 1_
- $a Abreu, Ana $u 9 Hospital Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.
- 700 1_
- $a Aguiar, Carlos $u 1 European Society of Cardiology, Sophia Antipolis, France. 10 Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal.
- 700 1_
- $a Badariene, Jolita $u 11 Clinic of Cardiac and Vascular diseases, Medical Faculty, Vilnius University, Lithuania. 12 Centre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Lithuania.
- 700 1_
- $a Bruthans, Jan $u 1 European Society of Cardiology, Sophia Antipolis, France. 13 Centre for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Czech Republic.
- 700 1_
- $a Castro Conde, Almudena $u 14 Cardiac Rehabilitation Unit, Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.
- 700 1_
- $a Cifkova, Renata $u 1 European Society of Cardiology, Sophia Antipolis, France. 13 Centre for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer Hospital, Czech Republic.
- 700 1_
- $a Crowley, Jim $u 1 European Society of Cardiology, Sophia Antipolis, France. 15 Department of Cardiology, Galway University Hospital and Croí, the West of Ireland Cardiac and Stroke Foundation, Croí Heart and Stroke Centre, Galway, Ireland.
- 700 1_
- $a Davletov, Kairat $u 16 School of Public Health, Public Health Research Centre, Kazakh National Medical University, Almaty, Kazakhstan.
- 700 1_
- $a Deckers, Jaap $u 1 European Society of Cardiology, Sophia Antipolis, France. 17 Erasmus MC, Rotterdam, The Netherlands.
- 700 1_
- $a De Smedt, Delphine $u 1 European Society of Cardiology, Sophia Antipolis, France. 3 Department of Public Health and Primary Care, Ghent University, Belgium.
- 700 1_
- $a De Sutter, Johan $u 1 European Society of Cardiology, Sophia Antipolis, France. 18 Department of Internal Medicine and Paediatrics, Ghent University, Belgium. 19 AZ Maria Middelares Ghent, Belgium.
- 700 1_
- $a Dilic, Mirza $u 1 European Society of Cardiology, Sophia Antipolis, France. 20 Medical Faculty, University of Sarajevo, Bosnia and Herzegovina.
- 700 1_
- $a Dolzhenko, Marina $u 21 Supyk National Medical Academy of Postgraduate Education, Kiev, Ukraine.
- 700 1_
- $a Dzerve, Vilnis $u 1 European Society of Cardiology, Sophia Antipolis, France. 22 Institute of Cardiology and Regenerative Medicine, University of Latvia, Riga, Latvia.
- 700 1_
- $a Erglis, Andrejs $u 1 European Society of Cardiology, Sophia Antipolis, France. 23 Pauls Stradins Clinical University Hospita, University of Latvia, Riga, Latvia.
- 700 1_
- $a Fras, Zlatko $u 1 European Society of Cardiology, Sophia Antipolis, France. 24 Preventive Cardiology Unit, Department of Vascular Medicine, Division of Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia. 25 Medical Faculty, University of Ljubljana, Slovenia.
- 700 1_
- $a Gaita, Dan $u 1 European Society of Cardiology, Sophia Antipolis, France. 26 Universitatea de Medicina si Farmacie Victor Babes, Institutul de Boli Cardiovasculare, Clinica de Recuperare Cardiovasculara, Timisoara, Romania.
- 700 1_
- $a Gotcheva, Nina $u 27 National Heart Hospital, Dept Cardiology, Sofia, Bulgaria.
- 700 1_
- $a Heuschmann, Peter $u 28 Institute of Clinical Epidemiology and Biometry, University of Würzburg, Germany. 29 Clinical Trial Centre, University Hospital Würzburg, Germany. 30 Comprehensive Heart Failure Centre, University and University Hospital Würzburg, Germany.
- 700 1_
- $a Hasan-Ali, Hosam $u 31 Assiut University Heart Hospital, Cardiovascular Medicine Department, Egypt.
- 700 1_
- $a Jankowski, Piotr $u 32 Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland.
- 700 1_
- $a Lalic, Nebojsa $u 33 Department for Metabolic Disorder, Intensive Treatment and Cell Therapy in Diabetes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Belgrade, Serbia.
- 700 1_
- $a Lehto, Seppo $u 1 European Society of Cardiology, Sophia Antipolis, France. 34 Varkaus Hospital, Finland.
- 700 1_
- $a Lovic, Dragan $u 1 European Society of Cardiology, Sophia Antipolis, France. 35 Clinic for Internal Disease Intermedic, Cardiology Department, Hypertension Centre, Nis, Serbia.
- 700 1_
- $a Mancas, Silvia $u 26 Universitatea de Medicina si Farmacie Victor Babes, Institutul de Boli Cardiovasculare, Clinica de Recuperare Cardiovasculara, Timisoara, Romania.
- 700 1_
- $a Mellbin, Linda $u 1 European Society of Cardiology, Sophia Antipolis, France. 4 Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Milicic, Davor $u 1 European Society of Cardiology, Sophia Antipolis, France. 36 University of Zagreb School of Medicine & University Hospital Centre Zagreb, Croatia.
- 700 1_
- $a Mirrakhimov, Erkin $u 1 European Society of Cardiology, Sophia Antipolis, France. 37 Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan. 38 National Centre of Cardiology and Internal Medicine named after academician Mirrakhimov MM, Bishkek, Kyrgyzstan.
- 700 1_
- $a Oganov, Rafael $u 39 National Research Centre for Preventive Medicine, Directorate, Moscow, Russia.
- 700 1_
- $a Pogosova, Nana $u 40 Federal State Budget Organization, National Medical Research Centre of Cardiology of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
- 700 1_
- $a Reiner, Zeljko $u 1 European Society of Cardiology, Sophia Antipolis, France. 41 University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Croatia.
- 700 1_
- $a Stöerk, Stefan $u 30 Comprehensive Heart Failure Centre, University and University Hospital Würzburg, Germany. 42 Department of Medicine I, University Hospital Würzburg, Germany.
- 700 1_
- $a Tokgözoğlu, Lâle $u 1 European Society of Cardiology, Sophia Antipolis, France. 43 Department of Cardiology, Hacettepe University, Ankara, Turkey.
- 700 1_
- $a Tsioufis, Costas $u 1 European Society of Cardiology, Sophia Antipolis, France. 44 First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Greece.
- 700 1_
- $a Vulic, Dusko $u 45 Centre for Medical Research, School of Medicine, University of Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
- 700 1_
- $a Wood, David $u 1 European Society of Cardiology, Sophia Antipolis, France. 2 National Heart and Lung Institute, Imperial College London, UK. 46 National University of Ireland, Galway, Ireland *Listed in Supplemental Appendix.
- 710 2_
- $a EUROASPIRE Investigators*
- 773 0_
- $w MED00188754 $t European journal of preventive cardiology $x 2047-4881 $g Roč. 26, č. 8 (2019), s. 824-835
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30739508 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222154124 $b ABA008
- 999 __
- $a ok $b bmc $g 1600016 $s 1116557
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 26 $c 8 $d 824-835 $e 20190210 $i 2047-4881 $m European journal of preventive cardiology $n Eur J Prev Cardiol $x MED00188754
- LZP __
- $a Pubmed-20201125
